EP3810201 - GIP/GLP1 AGONIST COMPOSITIONS [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 05.05.2023 Database last updated on 26.04.2025 | |
Former | Grant of patent is intended Status updated on 23.03.2023 | ||
Former | Examination is in progress Status updated on 24.03.2022 | ||
Former | Request for examination was made Status updated on 08.02.2022 | ||
Former | Grant of patent is intended Status updated on 04.11.2021 | ||
Former | Request for examination was made Status updated on 26.03.2021 | ||
Former | The international publication has been made Status updated on 27.12.2019 | ||
Former | unknown Status updated on 23.07.2019 | Most recent event Tooltip | 05.02.2025 | New entry: Date of oral proceedings | Applicant(s) | For all designated states Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | [2021/17] | Inventor(s) | 01 /
CORVARI, Vincent John c/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | 02 /
MINIE, Christopher Sears c/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | 03 /
MISHRA, Dinesh Shyandeo c/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | 04 /
QIAN, Ken Kangyi c/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | [2021/17] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
Former [2021/17] | Bassinder, Emma Marie Eli Lilly and Company Limited 8 Arlington Square West Downshire Way Bracknell, Berkshire RG12 1PU / GB | Application number, filing date | 19739766.4 | 14.06.2019 | [2021/17] | WO2019US37146 | Priority number, date | US201862688632P | 22.06.2018 Original published format: US 201862688632 P | [2021/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2019245893 | Date: | 26.12.2019 | Language: | EN | [2019/52] | Type: | A2 Application without search report | No.: | EP3810201 | Date: | 28.04.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.12.2019 takes the place of the publication of the European patent application. | [2021/17] | Type: | B1 Patent specification | No.: | EP3810201 | Date: | 07.06.2023 | Language: | EN | [2023/23] | Type: | B9 Corrected patent specification | No.: | EP3810201 | Date: | 02.08.2023 | [2023/31] | Search report(s) | International search report - published on: | EP | 12.03.2020 | Classification | IPC: | A61K47/02, A61K47/10, A61K38/26, A61P3/10 | [2021/46] | CPC: |
A61K47/02 (EP,CN,IL,KR,US);
A61K38/16 (IL,US);
A61K9/0021 (EP,IL,KR);
A61K38/26 (EP,CN,IL,KR);
A61K47/10 (EP,IL,US);
A61K9/0019 (EP,IL,US);
|
Former IPC [2021/17] | A61K47/02, A61K47/10, A61K38/00, A61K38/16, A61P3/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/17] | Extension states | BA | 22.01.2021 | ME | 22.01.2021 | Validation states | MA | 22.01.2021 | MD | 22.01.2021 | TN | 22.01.2021 | Title | German: | GIP/GLP1-AGONIST-ZUSAMMENSETZUNGEN | [2021/17] | English: | GIP/GLP1 AGONIST COMPOSITIONS | [2021/17] | French: | COMPOSITIONS AGONISTES GIP/GLP1 | [2021/17] | Entry into regional phase | 22.01.2021 | National basic fee paid | 22.01.2021 | Designation fee(s) paid | 22.01.2021 | Examination fee paid | Examination procedure | 16.12.2020 | Amendment by applicant (claims and/or description) | 22.01.2021 | Examination requested [2021/17] | 22.01.2021 | Date on which the examining division has become responsible | 05.11.2021 | Communication of intention to grant the patent | 08.02.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 23.03.2022 | Despatch of a communication from the examining division (Time limit: M04) | 19.05.2022 | Reply to a communication from the examining division | 24.03.2023 | Communication of intention to grant the patent | 26.04.2023 | Fee for grant paid | 26.04.2023 | Fee for publishing/printing paid | 26.04.2023 | Receipt of the translation of the claim(s) | Divisional application(s) | EP23176507.4 / EP4257185 | Opposition(s) | Opponent(s) | 01
23.02.2024
06.03.2024
ADMISSIBLE Sandoz AG Centralbahnstrasse 4 4051 Basel / CH Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | 02
05.03.2024
06.03.2024
ADMISSIBLE Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | 03
06.03.2024
07.03.2024
ADMISSIBLE STRAWMAN LIMITED Orchard Lea Horns Lane Combe Witney, Oxfordshire OX29 8NH / GB Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | 04
06.03.2024
07.03.2024
ADMISSIBLE Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN 13 1XR / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | 05
07.03.2024
08.03.2024
ADMISSIBLE Bülle Dr., Jan Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE Opponent's representative Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | 06
07.03.2024
08.03.2024
ADMISSIBLE Galenicum Health S.L.U. CL Sant Gabriel n°50 08950 Esplugues de Llobregat / ES Opponent's representative Galenicum Health S.L.U. CL Sant Gabriel n°50 08950 Esplugues de Llobregat / ES | 07
07.03.2024
08.03.2024
ADMISSIBLE Generics [UK] Limited Building 4, Trident Place Mosquito Way Hatfield Hertfordshire AL10 9UL / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | [2025/10] |
Former [2025/03] | |||
Opponent(s) | 01
23.02.2024
06.03.2024
ADMISSIBLE Sandoz AG Lichtstrasse 35 4056 Basel / CH Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | ||
02
05.03.2024
06.03.2024
ADMISSIBLE Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | |||
03
06.03.2024
07.03.2024
ADMISSIBLE STRAWMAN LIMITED Orchard Lea Horns Lane Combe Witney, Oxfordshire OX29 8NH / GB Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | |||
04
06.03.2024
07.03.2024
ADMISSIBLE Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN 13 1XR / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
05
07.03.2024
08.03.2024
ADMISSIBLE Bülle Dr., Jan Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE Opponent's representative Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | |||
06
07.03.2024
08.03.2024
ADMISSIBLE Galenicum Health S.L.U. CL Sant Gabriel n°50 08950 Esplugues de Llobregat / ES Opponent's representative Galenicum Health S.L.U. CL Sant Gabriel n°50 08950 Esplugues de Llobregat / ES | |||
07
07.03.2024
08.03.2024
ADMISSIBLE Generics [UK] Limited Building 4, Trident Place Mosquito Way Hatfield Hertfordshire AL10 9UL / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
Former [2024/16] | |||
Opponent(s) | 01
23.02.2024
06.03.2024
ADMISSIBLE Sandoz AG Lichtstrasse 35 4056 Basel / CH Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | ||
02
05.03.2024
06.03.2024
ADMISSIBLE Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | |||
03
06.03.2024
07.03.2024
ADMISSIBLE STRAWMAN LIMITED Orchard Lea Horns Lane Combe Witney, Oxfordshire OX29 8NH / GB Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | |||
04
06.03.2024
07.03.2024
ADMISSIBLE Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN 13 1XR / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
05
07.03.2024
08.03.2024
ADMISSIBLE Bülle Dr., Jan Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE Opponent's representative Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | |||
06
07.03.2024
08.03.2024
ADMISSIBLE Galenicum Health S.L.U. CL Sant Gabriel n°50 08950 Esplugues de Llobregat / ES Opponent's representative Torrejón-Nieto, Javier Galenicum Health S.L.U. CL Sant Gabriel nº50 08950 Esplugues de Llobregat / ES | |||
07
07.03.2024
08.03.2024
ADMISSIBLE Generics [UK] Limited Building 4, Trident Place Mosquito Way Hatfield Hertfordshire AL10 9UL / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
Former [2024/15] | |||
Opponent(s) | 01
23.02.2024
06.03.2024
ADMISSIBLE Sandoz AG Lichtstrasse 35 4056 Basel / CH Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | ||
02
05.03.2024
06.03.2024
ADMISSIBLE Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | |||
03
06.03.2024
07.03.2024
ADMISSIBLE STRAWMAN LIMITED Orchard Lea Horns Lane Combe Witney, Oxfordshire OX29 8NH / GB Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | |||
04
06.03.2024
07.03.2024
ADMISSIBLE Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN 13 1XR / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | |||
Former [2024/14] | |||
Opponent(s) | 01
23.02.2024
Sandoz AG Lichtstrasse 35 4056 Basel / CH Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | 20.03.2024 | Invitation to proprietor to file observations on the notice of opposition | 20.09.2024 | Reply of patent proprietor to notice(s) of opposition | 25.11.2025 | Date of oral proceedings | Fees paid | Renewal fee | 30.06.2021 | Renewal fee patent year 03 | 30.06.2022 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SM | 07.06.2023 | [2024/08] | Cited in | International search | [A]US2012329708 (DIMARCHI RICHARD D [US], et al); | [A]US9474780 (BOKVIST BENGT KRISTER [US], et al) | by applicant | US8734394 | US9474780 | Opposition | WO2004105790 | US8114833 | US8734394 | US9474780 | US2017136092 | WO2019245893 | EP0619322 | WO03002136 | WO2008019147 | WO2014005858 | CN103893744 | WO2015104311 | WO2018103868 | US2012329708 | WO2005049061 | WO2006051103 | WO2012177443 | WO2014081849 | WO2014202780 | WO2015022400 | WO2015071355 | WO2013164483 | WO2006051110 | WO2014166836 |